|
C20ORF11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69620000004078E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.250150E-02 |
| Normal-vs-Stage2 |
5.74330000002732E-07 |
| Normal-vs-Stage3 |
6.5313000008338E-08 |
| Normal-vs-Stage4 |
3.99809996221023E-09 |
| Stage1-vs-Stage2 |
1.463380E-03 |
| Stage1-vs-Stage3 |
1.180010E-04 |
| Stage1-vs-Stage4 |
1.85120999999233E-05 |
| Stage2-vs-Stage3 |
7.730200E-01 |
| Stage2-vs-Stage4 |
6.191400E-01 |
| Stage3-vs-Stage4 |
3.701200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66599999998451E-06 |
| Normal-vs-AfricanAmerican |
6.585800E-04 |
| Normal-vs-Asian |
3.574400E-01 |
| Caucasian-vs-AfricanAmerican |
7.333400E-01 |
| Caucasian-vs-Asian |
4.503000E-01 |
| AfricanAmerican-vs-Asian |
4.364200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0201000000265E-06 |
| Normal-vs-Female |
3.441100E-04 |
| Male-vs-Female |
1.617020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.759900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.2283999999928E-05 |
| Normal-vs-Age(61-80Yrs) |
3.62179999999768E-05 |
| Normal-vs-Age(81-100Yrs) |
4.556100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.687200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.601600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.954600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.723400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.083400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.092800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.850800E-01 |
| Normal-vs-Grade 2 |
7.684900E-03 |
| Normal-vs-Grade 3 |
3.10520000046388E-07 |
| Normal-vs-Grade 4 |
8.02610200523191E-11 |
| Grade 1-vs-Grade 2 |
2.904000E-01 |
| Grade 1-vs-Grade 3 |
2.406100E-02 |
| Grade 1-vs-Grade 4 |
1.607370E-04 |
| Grade 2-vs-Grade 3 |
7.562100E-04 |
| Grade 2-vs-Grade 4 |
1.21290000043572E-07 |
| Grade 3-vs-Grade 4 |
1.308100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.980100E-02 |
| Normal-vs-ccB subtype |
9.47029999975868E-08 |
| ccA subtype-vs-ccB subtype |
1.22020000004053E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.66370000004501E-06 |
| Normal-vs-N1 |
2.601800E-04 |
| N0-vs-N1 |
1.652840E-01 |
|
|
